mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.021 |
0.6 |
mRNA |
BRD-A02303741 |
CTRPv2 |
pan-cancer |
AAC |
-0.024 |
0.6 |
mRNA |
niclosamide |
CTRPv2 |
pan-cancer |
AAC |
-0.022 |
0.6 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.6 |
mRNA |
Mdivi-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.022 |
0.6 |
mRNA |
BRD-K78574327 |
CTRPv2 |
pan-cancer |
AAC |
0.043 |
0.6 |
mRNA |
BRD-K27986637 |
CTRPv2 |
pan-cancer |
AAC |
-0.042 |
0.6 |
mRNA |
MLN4924 |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.6 |
mRNA |
SNX-2112 |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.6 |
mRNA |
CHEMBL374350 |
CTRPv2 |
pan-cancer |
AAC |
0.022 |
0.6 |